The most serious adverse drug reactions from controlled clinical trials rarely reported (<1%) were bleeding and clotting disorders including gastrointestinal hemorrhage, hemorrhagic ulcer and hemothorax.
Bleeding Disorders: Agranulocytosis/granulocytopenia, aplastic anemia, neutropenia and thrombocytopenia.
Gastrointestinal System Disorders: Duodenal, gastric or peptic ulcer, gastritis.
Skin Disorders: Any rash and bullous eruption.
View ADR Monitoring Form